PILOT
831175
XINGANJIANG
873167
CHENGUANG MEDICAL
430300
4
Beijing Highlander Digital Technology
300065
5
Hangzhou Gaoxin Materials Technology
300478
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -93.12%3.2M | -109.67%-7M | -665.68%-153.3M | 33.61%907.9M | 32.99%761.9M | -89.13%46.5M | 147.38%72.4M | 116.08%27.1M | ||
Net income from continuing operations | ---- | ---- | 459.78%103M | -19.31%76.9M | -3.24%65.8M | 59.16%266.6M | -4.28%84.9M | 141.72%18.4M | 179.47%95.3M | -23.42%68M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | 274.65%150.9M | --80.8M | ---- | ---- | ---- |
Depreciation and amortization | ---- | ---- | 20.74%81.5M | 18.81%79.6M | 17.37%78.4M | 4.66%276.2M | 13.83%74.9M | 2.12%67.5M | 2.29%67M | 0.45%66.8M |
Deferred tax | ---- | ---- | ---- | ---- | ---- | 64.62%-21.3M | ---- | ---- | ---- | ---- |
Other non cash items | ---- | ---- | -114.14%-5.5M | 244.83%4.2M | -12.59%11.8M | -86.29%24.1M | -130.86%-25.4M | 23.89%38.9M | -103.04%-2.9M | 140.66%13.5M |
Change In working capital | ---- | ---- | -13.60%-213.9M | -52.27%-221.7M | -87.49%-359.8M | 97.24%-5.4M | 48.94%520.4M | -196.61%-188.3M | 62.23%-145.6M | 45.84%-191.9M |
-Change in receivables | ---- | ---- | ---- | ---- | ---- | 67.63%-195.1M | ---- | ---- | ---- | ---- |
-Change in prepaid assets | ---- | ---- | ---- | ---- | ---- | 250.68%44.3M | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | ---- | ---- | -64.11%153.6M | ---- | ---- | ---- | ---- |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | -195.35%-8.2M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -46.98%481.4M | -16.21%638.4M | -92.90%3.3M | -109.67%-7M | -665.68%-153.3M | 33.63%907.9M | 33.01%761.9M | -89.14%46.5M | 147.41%72.4M | 116.06%27.1M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 55.07%-960.7M | 58.26%-236.6M | -29.04%-321.3M | 67.36%-85M | 70.08%-317.8M | -198.40%-2.14B | -973.67%-566.9M | -368.93%-249M | 48.34%-260.4M | -896.25%-1.06B |
Net PPE purchase and sale | -2.58%-147.3M | 7.64%-38.7M | 3.85%-35M | -14.12%-39.6M | -11.11%-34M | -27.19%-143.6M | -12.03%-41.9M | -21.74%-36.4M | -62.15%-34.7M | -26.45%-30.6M |
Net intangibles purchase and sale | -13.33%-5.1M | --0 | --0 | ---5.1M | --0 | -36.36%-4.5M | --0 | --0 | --0 | ---4.5M |
Net business purchase and sale | 99.78%-900K | --0 | ---- | ---- | ---- | ---402M | ---246.3M | ---- | ---- | ---- |
Net investment purchase and sale | 49.16%-807.4M | 28.99%-197.9M | -403.16%-286.3M | 82.14%-40.3M | 72.45%-282.9M | -164.52%-1.59B | -1,709.74%-278.7M | -185.93%-56.9M | 53.24%-225.7M | -1,146.24%-1.03B |
Net other investing changes | --100K | --0 | --900K | --100K | ---900K | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 55.08%-960.6M | 58.26%-236.6M | -29.04%-321.3M | 67.40%-84.9M | 70.08%-317.8M | -198.35%-2.14B | -973.67%-566.9M | -368.05%-249M | 48.34%-260.4M | -896.25%-1.06B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -116.55%-260.4M | -66.14%-219.3M | -179.31%-187.8M | -148.83%-207.4M | -66.08%354.1M | 130.93%1.57B | 68.74%-132M | 86.60%236.8M | -39.89%424.7M | 286.31%1.04B |
Net issuance payments of debt | -52.44%505.9M | -181.12%-205.4M | 15.76%367.2M | -94.38%16.8M | 68.28%327.3M | 924.57%1.06B | 398.58%253.2M | 339.40%317.2M | 2,432.20%298.8M | 154.25%194.5M |
Net common stock issuance | -114.90%-652M | 28.12%-108.4M | -661.32%-370M | -3,125.81%-100M | 27.06%-73.6M | -7.28%-303.4M | -13.21%-150.8M | 29.57%-48.6M | 96.15%-3.1M | ---100.9M |
Proceeds from stock option exercised by employees | -675.00%-15.5M | ---- | ---- | ---- | ---- | 85.61%-2M | ---- | ---- | ---- | ---- |
Net other financing activities | -112.11%-98.7M | 147.38%110.1M | -481.76%-185M | -196.28%-124.2M | -89.43%100.4M | -26.38%815M | -22.12%-232.4M | -110.06%-31.8M | -83.38%129M | 363.29%950.2M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -116.54%-260.3M | -66.06%-219.2M | -179.31%-187.8M | -148.83%-207.4M | -66.08%354.1M | 130.93%1.57B | 68.74%-132M | 86.75%236.8M | -39.89%424.7M | 286.31%1.04B |
Net cash flow | ||||||||||
Beginning cash position | 19.91%2.23B | -38.03%1.31B | -16.08%1.78B | 10.71%2.08B | 19.91%2.23B | 47.97%1.86B | 24.41%2.12B | 68.94%2.12B | 50.52%1.88B | 47.98%1.86B |
Current changes in cash | -315.66%-739.5M | 189.84%182.6M | -1,574.34%-505.7M | -226.49%-299.4M | -1,414.61%-117M | -46.75%342.9M | -35.58%63M | -93.16%34.3M | 375.30%236.7M | 274.51%8.9M |
Effect of exchange rate changes | -295.26%-53.5M | -214.34%-57.4M | 207.69%39.2M | -310.53%-4M | -367.52%-31.3M | 166.67%27.4M | -16.89%50.2M | 32.97%-36.4M | 104.24%1.9M | 587.50%11.7M |
End cash Position | -35.56%1.44B | -35.56%1.44B | -38.03%1.31B | -16.08%1.78B | 10.71%2.08B | 19.91%2.23B | 19.91%2.23B | 24.41%2.12B | 68.94%2.12B | 50.52%1.88B |
Free cash flow | -56.70%329M | -16.71%599.7M | -413.86%-31.7M | -237.14%-51.7M | -2,241.25%-187.3M | 34.91%759.8M | 34.48%720M | -97.44%10.1M | 121.65%37.7M | 95.85%-8M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |